Table 1.
Summary of examples of virus–lipid interactions discussed in this review.
| Stage | Lipid class | Mode of action | Virus examples |
|---|---|---|---|
| Docking/fusion | Phosphatidylserines | PS addition causes a “glycosylation-specific enhancement” of virus entry | HIV (Coil and Miller, 2005b, Coil and Miller, 2005a) |
| Annexins are hijacked as co-receptors by PS expressed in the virus envelope | Influenza virus (Huang et al., 1996), HBV (Hertogs et al., 1993), HCMV (Raynor et al., 1999), RSVa (Malhotra et al., 2003), HIV (Callahan et al., 2003, Ma et al., 2004) | ||
| Molecular mimicry of apoptotic bodies facilitates macropinocytosis/virus entry | VACV (Mercer and Helenius, 2008) | ||
| Sterols/Sterol Esters | Association with apolipoproteins facilitates virus docking and subsequent entry steps | HCV (Prince et al., 1996, Agnello et al., 1999, Molina et al., 2007) | |
| Virus surface glycoproteins and receptors are clustered in “lipid rafts” | HCV (Kapadia et al., 2007, Burlone and Budkowska, 2009), HIV (Sorice et al., 2000, Sorice et al., 2001, Nguyen and Taub, 2002, Popik et al., 2002, Bhattacharya et al., 2004, Nguyen et al., 2005), RSVa (Fleming et al., 2006), influenza virus (Takeda et al., 2003) | ||
| Sphingolipids | Glycan–glycan interactions between host and virus stabilize virus attachment | Influenza virus (Huang, 1976, Leskawa et al., 1986, Kasson and Pande, 2008) | |
| GalCer, GM3 and Gb3 serve as auxiliary receptors for virus entry | HIV (Fantini et al., 1993, Seddiki et al., 1996, Hammache et al., 1999, Hug et al., 2000, Magerus-Chatinet et al., 2007) | ||
| GSLs aggregate viral receptors which have low endogenous cellular levels | EBOV, Marburg virus, VACV, HSV (reviewed in Teissier and Pecheur, 2007) | ||
| Gangliosides serve as main receptors for virus entry | SeV (Markwell et al., 1981, Hansson et al., 1984, Markwell et al., 1984, Muthing and Unland, 1994, Kaneda et al., 1997), NDV (Ferreira et al., 2004a, Ferreira et al., 2004b, Villar and Barroso, 2006) | ||
| Replication/translation | Phosphatidylserines | PS enriched in endosomal membranes is required by NSP1 for capping of viral mRNAs | SFV (Ahola et al., 1999) |
| Sterols/sterol esters | Nef accessory protein enhances cholesterol biosynthesis and impairs ABCA1 dependent cholesterol efflux | HIV (Mujawar et al., 2006) | |
| Sphingolipids | Enhanced levels of cholesterol are required to support formation of “lipid-raft” structures | RSVa (Money et al., 2009) | |
| Increased activity of SphK1 promotes accumulation of transcriptional activator IE1 | HCMV (Machesky et al., 2008) | ||
| Fatty acids | Genome replication is stimulated by saturated or monounsaturated fatty acids. FAS is highly enriched in the supernatant of infected cells | HCV (Su et al., 2002) | |
| Assembly/budding | Phosphoinositides | Gag binds specifically to PI(4,5)P2 causing a myristic switch in MA which increases membrane partitioning of Gag | HIV (Zhou et al., 1994, Ono et al., 2004, Freed, 2006) |
| Sterols | It is also possible that PI(4,5)P2 interactions with cellular proteins contribute to membrane curvature during virus assembly and budding | HIV (Chan et al., 2008) | |
| Surface exposed polybasic domains of similar matrix proteins also use phosphoinositides or other anionic phospholipids for “lipid-raft” targeting/induction of membrane curvature | Influenza virus (Ruigrok et al., 2000, Thaa et al., 2009), EBOV (Timmins et al., 2004), VSV (Gaudier et al., 2002), RSVa (Money et al., 2009) | ||
| Virus assembly occurs on lipid droplets | HCV (Miyanari et al., 2007) | ||
| Sphingolipids | Nef contains cholesterol binding sequence in its C terminus which allows transport to and association with lipid rafts | HIV (Zheng et al., 2003) | |
| Cholesterol depletion enhances virus budding | Influenza virus (Barman and Nayak, 2007) | ||
| Cholesterol depletion inhibits virus production | HIV (Ono and Freed, 2001, Pickl et al., 2001) | ||
| “Lipid-raft” dependent viruses do not co-localize on the plasma membrane | HIV, Influenza virus, EBOV (Khurana et al., 2007, Leung et al., 2008) | ||
| Fatty acids | Several viral proteins have myristoyl and palmitoyl covalent modifications for “lipid-raft” targeting | HIV, Influenza virus, EBOV, Marburg virus, measles virus, NDV, RSVa (reviewed in Hruby and Franke, 1993, Maurer-Stroh and Eisenhaber, 2004) | |
| Extracellular | Sterols/sterol esters | Cholesterol depletion of virus envelopes leads to virus inactivation due to a loss of protein core and genome integrity | HIV and SIV (Graham et al., 2003), influenza virus (Barman and Nayak, 2007, Ambrose et al., 2008) |
| Lipid molecular geometry | Inverted-cone shaped lipids like lyso PC inhibits virus envelope fusion with target membrane while cone shaped lipids like pPE, DAG and ceramide may facilitate membrane dynamics | HIV (Martin and Ruysschaert, 1995, Gunther-Ausborn and Stegmann, 1997, Brugger et al., 2006, Chan et al., 2008), TBEV (Stiasny and Heinz, 2004), influenza virus (Gunther-Ausborn et al., 1995, Chernomordik et al., 1998) | |